GlassScriptPhysician profile
Lucius Blanchard
NPI 1134147853
$14,094.33
in general payments reported to CMS, 2019-2025
46 companies · $2,159 in 2025
The $2,159 reported for 2025 was more than what 89% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,606 · 2020: $844 · 2021: $1,449 · 2022: $1,607 · 2023: $2,658 · 2024: $2,770 · 2025: $2,159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,352 · Education: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,352.19 |
| Education | $235.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,146.20 | 2019-2025 | Skyrizi, Rinvoq, Humira |
| Janssen Biotech, INC. | $1,510.14 | 2019-2025 | Tremfya |
| Amgen INC. | $1,138.54 | 2019-2025 | Otezla, Enbrel, Otezla |
| E.R. Squibb & Sons, L.L.C. | $1,065.80 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $1,048.85 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $772.15 | 2019-2025 | Libtayo, Dupixent |
| Pfizer INC. | $763.78 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $666.57 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $479.80 | 2019-2025 | Odomzo, Winlevi, Absorica Ld |
| Lilly USA, LLC | $346.84 | 2020-2025 | Taltz, Ebglyss, Olumiant |
| Dermavant Sciences, INC. | $339.27 | 2023-2024 | Vtama |
| Leo Pharma INC. | $280.76 | 2021-2025 | Adbry, Anzupgo |
| Ucb, INC. | $266.94 | 2019-2025 | Bimzelx, Cimzia |
| Genentech USA, INC. | $239.51 | 2019-2021 | |
| Celgene Corporation | $179.43 | 2019 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucius Blanchard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.